1.
Benjamin Hanfstein, Martin C. Müller, Sebastian Kreil, Thomas Ernst, Thomas Schenk, Christian Lorentz, Uwe Schwindel, Armin Leitner, Rüdiger Hehlmann, Andreas Hochhaus. Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy. haematol [Internet]. 2011Feb.28 [cited 2024Apr.19];96(3):360-6. Available from: https://haematologica.org/article/view/5897